Becton, Dickinson and Co. | BDX - Ebitda





Ebitda Alterar Data
Abbott USD 2.43B 844M 2026-03
Agilent USD 577M 77M 2026-06
Align Technology USD 232.86M 3.72M 2026-06
AngioDynamics USD 5.94M 3.78M 2025-09
Baxter International USD 474M 165M 2026-06
Becton, Dickinson and Co. USD 1.71B 1B 2026-06
Bio-Rad Laboratories USD 595.3M 1.23B 2026-06
Boston Scientific USD 1.63B 27M 2026-06
Cooper Companies USD 67.9M 255.5M 2026-03
Danaher USD 2.1B 257M 2026-09
Dentsply International USD 190M 61M 2026-06
Dexcom USD 435.2M 46.5M 2026-09
Edwards Lifesciences USD 555.6M 485.5M 2026-03
Globus Medical USD 279.84M 48.01M 2026-06
Insulet USD 199.8M 18.1M 2026-06
Integra LifeSciences USD 79.79M 1.37M 2026-09
Intuitive Surgical USD 1.2B 147.7M 2026-06
J&J USD 8.99B 721M 2026-06
Medtronic USD 2.63B 174M 2026-06
Solventum Corp USD 670M 233M 2026-06
Stryker USD 1.83B 102M 2026-09
Tandem Diabetes Care USD 6.42M 3.69M 2026-06
Teleflex USD 122.91M 47.28M 2026-06
Terumo JPY 116.67B 58.79B 2026-06
Thermo Fisher Scientific USD 3.79B 244M 2026-09
Zimmer Biomet Holdings USD 830.5M 190.4M 2026-06